| [1] |
Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care, 2007, 11: R31.
|
| [2] |
Wong F, Nadim MK, Kellum JA, et al. Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut, 2011, 60: 702-709.
|
| [3] |
Ostermann M. Diagnosis of acute kidney injury: Kidney Disease Improving Global Outcomescriteria and beyond. Curr Opin Crit Care, 2014, 20: 581-587.
|
| [4] |
Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidneydisease. Scand J Clin Lab Invest Suppl, 2008, 241: 89-94.
|
| [5] |
Zappitelli M, Washburn KK, Arikan AA, et al. Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care, 2007, 11: R84.
|
| [6] |
Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patientswith cirrhosis:revised consensus recommendations of the International Club of Ascites. Gut, 2015, 64: 531-537.
|
| [7] |
中华医学会传染病与寄生虫病学分会、肝病学分会. 病毒性肝炎防治方案. 中华传染病杂志, 2001, 19: 56-62.
|
| [8] |
Tomlanovich S, Golbetz H, Perlroth M, et al. Limitations of creatinine in quantifying theseverity of cyclosporine-induced chronic nephropathy. Am J Kidney Dis, 1986, 8: 332-337.
|
| [9] |
Moran SM, Myers BD. Course of acute renal failure studied by a model of creatinine. Kidney Int, 1985, 27: 928-937.
|
| [10] |
Star RA. Treatment of acute renal failure. Kidney Int, 1998, 54: 1817-1831.
|
| [11] |
Sherman DS, Fish DN, Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis, 2003, 41: 269-278.
|
| [12] |
Bolignano D, Donato V, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis, 2008, 52: 595- 605.
|
